Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.34 USD | +3.22% | +13.89% | +704.97% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+704.97% | 500M | |
+15.46% | 121B | |
+13.56% | 107B | |
-4.72% | 24.82B | |
+1.54% | 22.48B | |
-9.86% | 18.32B | |
-42.28% | 16.33B | |
-16.08% | 15.31B | |
+3.93% | 14.08B | |
+26.22% | 11.74B |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $60 From $58, Maintains Outperform Rating